title: Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression.
abstract: We generated mice expressing a COX-2 transgene in colon epithelium and found that they did not develop spontaneous colon tumors. But when treated with azoxymethane, a colon carcinogen, COX-2 mice had a higher tumor load compared to wild-type mice. There was no change in the number of pre-neoplastic lesions, indicating that COX-2 does not affect tumor initiation. Tumors in the COX-2 transgenic mice had higher levels of phosphorylated epidermal growth factor receptor and Akt compared to wild-type mice. Collectively, our data indicate that COX-2 promotes colon tumor progression, but not initiation, and it does so, in part, by activating EGFR and Akt signaling pathways.
authors.affiliation: Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Rm 3365, Salt Lake City, UT 84112, USA.
authors.forename: Mazin A
authors.initials: MA
authors.lastname: Al-Salihi
authors.forename: A
authors.initials: A
authors.lastname: Terrece Pearman
authors.forename: Thao
authors.initials: T
authors.lastname: Doan
authors.forename: Ethan C
authors.initials: EC
authors.lastname: Reichert
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Rosenberg
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Prescott
authors.forename: Diana M
authors.initials: DM
authors.lastname: Stafforini
authors.forename: Matthew K
authors.initials: MK
authors.lastname: Topham
mesh_terms: D000818:Animals; D051546:Cyclooxygenase 2 / Q000096:biosynthesis / Q000235:genetics*; D018450:Disease Progression; D004848:Epithelium / Q000378:metabolism*; D066246:ErbB Receptors / Q000378:metabolism*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D015398:Signal Transduction; D019076:Transgenes
chemical_list: D051546:Cyclooxygenase 2; D066246:ErbB Receptors; D051057:Proto-Oncogene Proteins c-akt
references.citation: Gut. 1994 May;35(5):675-8
references.pmid: 8200564
references.citation: J Biol Chem. 2001 May 25;276(21):18563-9
references.pmid: 11278747
references.citation: Recent Results Cancer Res. 2007;174:37-47
references.pmid: 17302183
references.citation: Toxicol Sci. 2005 Dec;88(2):340-5
references.pmid: 16150884
references.citation: J Biol Chem. 2004 Apr 2;279(14):14287-93
references.pmid: 14742435
references.citation: N Engl J Med. 1995 Sep 7;333(10):609-14
references.pmid: 7637720
references.citation: J Clin Oncol. 2005 Jan 10;23(2):254-66
references.pmid: 15637389
references.citation: Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):63-75
references.pmid: 15000150
references.citation: Cancer Res. 2005 Nov 1;65(21):10113-9
references.pmid: 16267038
references.citation: J Biol Chem. 1987 Nov 25;262(33):16060-71
references.pmid: 2824476
references.citation: N Engl J Med. 1991 Dec 5;325(23):1593-6
references.pmid: 1669840
references.citation: Cell Signal. 2007 Sep;19(9):1956-63
references.pmid: 17572069
references.citation: J Clin Invest. 1997 Sep 15;100(6):1325-9
references.pmid: 9294096
references.citation: Trends Pharmacol Sci. 2007 Jul;28(7):303-7
references.pmid: 17573128
references.citation: N Engl J Med. 2003 Mar 6;348(10):879-80
references.pmid: 12621130
references.citation: J Immunol. 1998 Feb 1;160(3):1402-10
references.pmid: 9570560
references.citation: Cancer Res. 2003 Sep 1;63(17):5218-23
references.pmid: 14500348
references.citation: Cancer Res. 2005 Jun 1;65(11):4496-9
references.pmid: 15930264
references.citation: Ann Intern Med. 1994 Aug 15;121(4):241-6
references.pmid: 8037405
references.citation: Carcinogenesis. 2003 Feb;24(2):307-15
references.pmid: 12584182
references.citation: Mol Cancer Ther. 2006 Jun;5(6):1530-8
references.pmid: 16818512
references.citation: N Engl J Med. 2007 May 24;356(21):2131-42
references.pmid: 17522398
references.citation: J Clin Invest. 2000 Jun;105(11):1589-94
references.pmid: 10841517
references.citation: Cancer Res. 2006 Oct 1;66(19):9665-72
references.pmid: 17018624
references.citation: Ann Intern Med. 2007 Mar 6;146(5):361-4
references.pmid: 17339621
references.citation: Nat Med. 2002 Mar;8(3):289-93
references.pmid: 11875501
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12483-8
references.pmid: 12221288
references.citation: FASEB J. 2003 Sep;17(12):1640-7
references.pmid: 12958170
references.citation: Oncogene. 2006 Nov 9;25(53):7019-28
references.pmid: 16732324
references.citation: J Biol Chem. 2003 Sep 12;278(37):35451-7
references.pmid: 12824187
references.citation: J Biol Chem. 1993 Aug 25;268(24):18345-58
references.pmid: 8349710
references.citation: Cancer Res. 2005 Mar 1;65(5):1822-9
references.pmid: 15753380
references.citation: Hepatology. 2007 Mar;45(3):631-8
references.pmid: 17326157
references.citation: Gastroenterology. 1999 Oct;117(4):858-65
references.pmid: 10500068
references.citation: J Clin Invest. 2004 Dec;114(11):1676-85
references.pmid: 15578100
references.citation: Genes Dev. 1988 Oct;2(10):1318-32
references.pmid: 2462524
references.citation: Cancer Sci. 2004 Apr;95(4):316-20
references.pmid: 15072589
references.citation: Cancer Res. 1997 Aug 15;57(16):3465-70
references.pmid: 9270014
references.citation: Gastroenterology. 2003 Mar;124(3):762-77
references.pmid: 12612914
references.citation: Curr Pharm Des. 2004;10(6):635-46
references.pmid: 14965326